Compare Bintang Samudera Mandiri Lines Tbk (BSML) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bintang Samudera Mandiri Lines Tbk vs Merck Tbk. — how do they compare? Bintang Samudera Mandiri Lines Tbk trades at Rp515 (market cap 962.12B, 5.72M 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 36.2K 24h volume). The key difference: Merck Tbk. is the larger of the two by market cap, and Bintang Samudera Mandiri Lines Tbk is more actively traded (5.72M versus 36.2K). Which is the better fit depends on your goals.
| BSML | MERK | |
|---|---|---|
Market Cap | 962.12B | 1.7T |
Volume | 5.72M | 36.2K |
Lot | 57.2K | 362 |
Turnover | 2.99B | 139.09M |
Average Price | 522.62 | 3,842.32 |
Value | 2.99B | 139.09M |
Indicative Equilibrium Price | 520 | 3,850 |
Indicative Equilibrium Volume | 30 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bintang Samudera Mandiri Lines Tbk
PT Bintang Samudera Mandiri Lines Tbk (the Company) was established based on Notarial Deed No. 101 of Fransiskus Djoenardi, S.H., dated November 17, 2007. The Company has started its operations since 2017.
Read more on BSML →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
